Also... this seems strongly at odds with the last appendix 4C....

Also... this seems strongly at odds with the last appendix 4C. The company stated:

Strong balance sheet to advance ResApp through commercialisation. The company held
cash of $3.9 million as of December 31, 2019. ResApp received a $1.8 million R&D tax
incentive cash rebate from its FY2019 R&D spend during the quarter. A significant proportion
of R&D spend for the current financial year will also be eligible for the R&D tax incentive.

The company claimed to have sufficient funds to "advance ResApp through commercialisation". Yet now we suddenly need cash. I'm feeling just a little bit misled right now. And that has legal implications for the directors.